期刊文献+

口服生物黏附给药系统的研究进展 被引量:3

原文传递
导出
摘要 目的:综述口服生物黏附给药系统(BDDS)的研究进展。方法:根据文献,综述了口服BDDS的黏附机制、生物黏附材料、生物黏附性能的评价方法以及应用情况。结果与结论:口服BDDS的黏附机制主要包括非特异性生物黏附机制与特异性生物黏附(细胞黏附)机制;非特异性生物黏附材料包括纤维素类、非纤维素多糖类、蛋白类和聚乙烯类材料等,特异性生物黏附材料中最常用的为凝集素(一种糖蛋白);可通过黏附力测定法、灌流冲洗法等体外法和肠道灌流法、荧光标记法等体内法对生物黏附性能进行评价;口服BDDS不仅能延长药物在胃肠道的滞留时间,提高其生物利用度,还可实现在食道、胃、小肠及结肠的定位释药。口服BDDS已逐渐显示出其优势,特别是在生物大分子药物的口服给药方面拥有广阔的应用前景。
出处 《中国药房》 CAS CSCD 2012年第13期1239-1241,共3页 China Pharmacy
  • 相关文献

参考文献23

  • 1Nagai T.Topical mucosal adhesive dosage forms[J].Med Res Rev,1986,6(2):227.
  • 2Serra L,Domenech J,Peppas NA.Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents[J].Eur J Pharm Biopharm,2009,71(3):519.
  • 3Woodley J.Bioadhesion:new possibilities for drug administration?[J].Clin Pharmacokinet,2001,40(2):77.
  • 4E.马西威兹,D.E.奇切林三世著.孙志杰译.生物黏附药物传输系统--基本原理、新方法及其进展[M].北京:化学工业出版社,2005:77-235.
  • 5胡晋红.现代给药系统的理论和实践[M].北京:人民军医出版社,2004:100.
  • 6Yeh TH,Hsu LW,Tseng MT,et al.Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening[J].Biomaterials,2011,32(26):6164.
  • 7Palmberger TF,Albrecht K,Loretz B,et al.Thiolated polymers:evaluation of the influence of the amount of covalently attached L-cysteine to poly(acrylic acid)[J].Eur J Pharm Biopharm,2007,66(3):405.
  • 8Andrews GP,Laverty TP,Jones DS.Mucoadhesive polymeric platforms for controlled drug delivery[J].Eur J Pharm Biopharm,2009,71(3):505.
  • 9魏科达,方平飞,赵绪元.胃肠道特异性生物黏附给药系统的研究进展[J].中国医药工业杂志,2010,41(1):55-58. 被引量:3
  • 10Thakral NK,Ray AR,Majumdar DK.Eudragit S-100entrapped chitosan microspheres of valdecoxib for colon cancer[J].J Mater Sci Mater Med,2010,21(9):2691.

二级参考文献82

  • 1裘建成,高永良.胃肠道生物黏附给药系统研究进展[J].中国新药杂志,2005,14(7):830-834. 被引量:7
  • 2尹雅姝,陈大为,乔明曦,胡海洋,秦晶.凝集素修饰乳酸-羟基乙酸共聚物纳米粒的制备及体外黏附性能评价[J].药学学报,2007,42(5):550-556. 被引量:6
  • 3Woodley JF. Lectins for gastrointestinal targeting--15 years on [J]. JDrug Target, 2000, 7(5): 325-333.
  • 4Clark MA, Hirst BH, Jepson MA. Lectin-mediated mucosal delivery of drugs and microparticles [J]. Adv Drug Deliv Rev, 2000, 43 (2-3) : 207-223.
  • 5Bies C, Lehr CM, Woodley JF. Lectin-mediated drug targeting: history and applications [J]. Adv Drug Deliv Rev, 2004, 56 (4) : 425-435.
  • 6Lehr CM. Lectin-mediated drug delivery: the second generation of bioadhesives [J]. J Controlled Release, 2000, 65(1-2): 19-29.
  • 7Gabor F, Stangl M, Wirth M. Lectin-mediated bioadhesion: binding characteristics of plant lectins on the enterocyte-like cell lines Caco-2, HT-29 and HCT-8 [J]. J Controlled Release, 1998, 55(2-3): 131-142.
  • 8Yin Y, Chen D, Qiao M, et al. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin [J]. J Controlled Release, 2006, 116 (3) : 337-345.
  • 9Yin Y, Chen D, Qiao M, et al. Lectin-conjugated PLGA nanopartieles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution [J]. J Controlled Release, 2007, 123(1): 27-38.
  • 10Russell-Jones G J, Alpers DH. Vitamin B12 transporters [J]. Pharm Biotechnol, 1999, 12: 493-520.

共引文献7

同被引文献28

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部